Skip to content
Politically.com Search all
Menu

Proposed rule 2026-13821

Schedules of Controlled Substances: Placement of Tianeptine in Schedule I

The Drug Enforcement Administration proposes placing the substance tianeptine (7-[(3-chloro-6,11-dihydro-6-methyl-5,5- dioxidodibenzo[c,f][1,2]thiazepin-11-yl)amino]heptanoic acid), including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers whenever the existence of such isomers, esters, ethers, salts, and salts of isomers, esters, and ethers is possible, in schedule I of the Controlled Substances Act. If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle tianeptine.

Source: FederalRegister.gov API v1Recently refreshed. Last successful refresh: 2026-07-31 22:49:02 UTC.

Source-supplied record

Document details

Document number
2026-13821
Published
Jul 8, 2026
Effective
Not supplied
Comments close
Aug 7, 2026 (open)
Federal Register citation
91 FR 42150

Docket identifiers

  • Docket No. DEA1596

CFR references

  • Title 21, part 1308